Zealand Pharma A/S (ZEAL.CO)
Company Info
Highlights
DKK 55.35B
-DKK 16.73
0.31
DKK 53.64M
DKK 39.55M
-DKK 730.64M
DKK 468.00 - DKK 972.00
DKK 986.58
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of DKK 10,000 in Zealand Pharma A/S, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Zealand Pharma A/S had a return of 7.76% year-to-date (YTD) and 58.45% in the last 12 months. Over the past 10 years, Zealand Pharma A/S had an annualized return of 25.11%, outperforming the S&P 500 benchmark which had an annualized return of 11.31%.
ZEAL.CO
7.76%
10.62%
-11.78%
58.45%
22.72%
25.11%
^GSPC (Benchmark)
4.46%
2.46%
9.31%
23.49%
13.03%
11.31%
Monthly Returns
The table below presents the monthly returns of ZEAL.CO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2.80% | 7.76% | |||||||||||
| 2024 | 26.53% | 40.62% | 2.64% | -7.12% | 1.03% | 39.56% | 4.20% | -4.68% | -8.29% | -2.77% | -7.65% | -1.99% | 91.72% |
| 2023 | 5.66% | 5.45% | -4.28% | 6.24% | 16.83% | -8.25% | -3.68% | 9.00% | 19.08% | -4.25% | 14.75% | 11.07% | 85.30% |
| 2022 | -11.58% | -20.58% | 2.26% | -22.84% | 22.76% | -5.98% | 41.16% | 0.92% | 31.47% | 11.74% | 3.71% | -0.00% | 38.80% |
| 2021 | -10.56% | -1.06% | 2.77% | 1.20% | -9.31% | 0.60% | 2.65% | 2.05% | -4.64% | 11.35% | -33.83% | 6.46% | -34.22% |
| 2020 | 3.91% | -1.23% | -3.31% | 1.11% | 11.77% | -13.86% | -3.96% | 8.97% | 1.51% | -11.75% | 11.82% | -7.47% | -6.29% |
| 2019 | 14.44% | 2.76% | 22.60% | 15.40% | 0.15% | 3.93% | 6.45% | -14.75% | 34.67% | 14.45% | 4.51% | 12.85% | 185.68% |
| 2018 | 19.53% | -6.79% | -1.69% | 0.11% | 3.11% | -12.59% | 13.21% | -2.73% | 13.73% | -20.25% | -1.79% | -0.00% | -3.06% |
| 2017 | 9.39% | -1.29% | -2.17% | 8.44% | -2.46% | 9.66% | -4.21% | -4.80% | 2.10% | -2.88% | -25.00% | -3.95% | -20.19% |
| 2016 | -16.50% | -5.14% | 12.50% | -4.44% | -3.88% | -3.63% | 8.37% | -13.51% | -12.05% | -4.57% | 17.02% | -3.18% | -29.70% |
| 2015 | 3.01% | -3.51% | 26.06% | -12.02% | 18.03% | 2.31% | 34.39% | -11.45% | 11.41% | 3.41% | -0.66% | 0.66% | 82.53% |
| 2014 | 24.58% | 2.72% | -8.61% | -3.62% | -4.51% | 10.24% | 2.86% | -1.39% | -2.82% | -1.45% | -1.47% | 23.88% | 40.68% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 79, ZEAL.CO is among the top 21% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Zealand Pharma A/S (ZEAL.CO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Zealand Pharma A/S. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Zealand Pharma A/S was 75.53%, occurring on May 16, 2022. Recovery took 336 trading sessions.
The current Zealand Pharma A/S drawdown is 19.18%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -75.53% | Feb 17, 2020 | 561 | May 16, 2022 | 336 | Sep 14, 2023 | 897 |
| -53.23% | Oct 28, 2015 | 794 | Dec 27, 2018 | 179 | Sep 18, 2019 | 973 |
| -51.59% | Dec 1, 2010 | 246 | Nov 22, 2011 | 82 | Mar 16, 2012 | 328 |
| -50% | May 2, 2012 | 353 | Oct 2, 2013 | 365 | Mar 23, 2015 | 718 |
| -29.3% | Jul 11, 2024 | 94 | Nov 19, 2024 | — | — | — |
Volatility
Volatility Chart
The current Zealand Pharma A/S volatility is 12.89%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Zealand Pharma A/S.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |